Healthpeak (DOC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Healthpeak reported Q3 2026 revenue of $820.89 million, beating Wall Street estimates of $758.25 million by 8.26%, with EPS of $0.44 versus consensus of $0.43. While the company showed strong revenue growth of 16.3% year-over-year and beat on several key metrics including resident fees and lab revenues, it underperformed on outpatient medical NOI and interest income. The stock carries a Zacks Rank #4 (Sell) rating and has underperformed the broader market over the past month.